Browse our anti-Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 (NFKB2) Antibodies

Full name:
anti-Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 Antibodies (NFKB2)
On www.antibodies-online.com are 0 Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 (NFKB2) Antibodies from different suppliers available. A total of 0 Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 products are currently listed.
Synonyms:
H2TF1, lyt, LYT-10, LYT10, NF-kappaB2, NF-kB2, p49, p49/p100, p50B, p52, p100, p105, RGD1307189, wu:fa03b02, zgc:136693
list all antibodies Gene Name GeneID UniProt
Anti-Mouse NFKB2 NFKB2 18034 Q9WTK5
Anti-Human NFKB2 NFKB2 4791 Q00653
Anti-Rat NFKB2 NFKB2 309452  

Show all synonyms

More Antibodies against Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 Interaction Partners

Mouse (Murine) Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 (NFKB2) interaction partners

  1. MKK4 (show MAP2K4 Antibodies) activates non-canonical NFkappaB signaling by promoting NFkappaB2-p100 (show PATL2 Antibodies) processing.

  2. the aberrant proliferative capacity of Brca1 (show BRCA1 Antibodies)(-/-) luminal progenitor cells is linked to the replication-associated DNA damage response, where proliferation of mammary progenitors is perpetuated by damage-induced, autologous NF-kappaB (show NFKB1 Antibodies) signaling.

  3. RelB (show RELB Antibodies) is processed by CO2 in a manner dependent on a key C-terminal domain located in its transactivation domain. Loss of the RelB (show RELB Antibodies) transactivation domain alters NF-kappaB (show NFKB1 Antibodies)-dependent transcriptional activity, and loss of p100 (show PATL2 Antibodies) alters sensitivity of RelB (show RELB Antibodies) to CO2

  4. the individual functions of the NF-kappaB (show NFKB1 Antibodies) family members NF-kappaB1 (show NFKB1 Antibodies), NF-kappaB2 and c-REL (show NFkBP65 Antibodies) in the various autoimmune pathologies of Fas(lpr/lpr (show FAS Antibodies)) mutant mice, were investigated.

  5. we identify in this study a critical role for the combined activity of the RELB (show RELB Antibodies) and NF-kappaB2 subunits in B cell homeostasis that cannot be compensated for by the canonical NF-kappaB (show NFKB1 Antibodies) pathway under physiological conditions.

  6. Mechanistically the LncRNA-HIT siRNA treatments impacted pro-chondrogenic gene expression by reducing H3K27ac or p100 (show PATL2 Antibodies) activity, confirming that LncRNA-HIT is essential for chondrogenic differentiation in the limb mesenchyme

  7. Nfkb2 connected lymphotoxin (show LTB Antibodies) signal within the intestinal niche in reinforcing epithelial innate inflammatory RelA (show NFkBP65 Antibodies)/NF-kappaB (show NFKB1 Antibodies) response to Citrobacter rodentium infection, while Nfkb2(-/-) mice succumbed to gut (show GUSB Antibodies) infections owing to stromal defects.

  8. Data indicate a coupled increase in the expression of renal, relA (show NFkBP65 Antibodies), NF-kB2, and p53 (show TP53 Antibodies) genes and proteins during folic acid induced acute kidney injury (AKI).

  9. Loss of c-REL (show NFkBP65 Antibodies) but not NF-kappaB2 prevents autoimmune disease driven by FasL (show FASL Antibodies) mutation.

  10. NF-kappaB2/p52 is necessary for the development of colitis, whilst c-Rel (show NFkBP65 Antibodies)-mediated signalling regulates colonic epithelial cell turnover following DNA damage.

Human Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 (NFKB2) interaction partners

  1. a new ERK2 (show MAPK1 Antibodies)/AP-1 (show FOSB Antibodies)/miR (show MLXIP Antibodies)-494/PTEN (show PTEN Antibodies) pathway that is responsible for the tumor-suppressive role of NFkappaB2 p100 (show CUX1 Antibodies) in cellular transformation.

  2. MKK4 (show MAP2K4 Antibodies) activates non-canonical NFkappaB (show NFKB1 Antibodies) signaling by promoting NFkappaB2-p100 (show CUX1 Antibodies) processing.

  3. the aberrant proliferative capacity of Brca1(-/-) luminal progenitor cells is linked to the replication-associated DNA damage response, where proliferation of mammary progenitors is perpetuated by damage-induced, autologous NF-kappaB (show NFKB1 Antibodies) signaling.

  4. RelB (show RELB Antibodies) is processed by CO2 in a manner dependent on a key C-terminal domain located in its transactivation domain. Loss of the RelB (show RELB Antibodies) transactivation domain alters NF-kappaB (show NFKB1 Antibodies)-dependent transcriptional activity, and loss of p100 (show CUX1 Antibodies) alters sensitivity of RelB (show RELB Antibodies) to CO2

  5. The expression levels of BRAFV600E and NF-kappaB (show NFKB1 Antibodies) were significantly greater in thyroglobuiln antibody-positive than in thyroglobuiln antibody-negative papillary thyroid carcinoma patients.

  6. Gene expression levels of NF-kappaB2 were deregulated in 49 B-cell chronic lymphocytic leukemia, 8 B-cell non-Hodgkin's lymphoma, 3 acute myeloid leukemia, 3 chronic myeloid leukemia, 2 hairy cell leukemia, 2 myelodysplastic syndrome, and 2 T-cell large granular lymphocytic leukemia patients in the post-Chernobyl period.

  7. melatonin transcriptionally inhibited MMP-9 (show MMP9 Antibodies) by reducing p65 (show GORASP1 Antibodies)- and p52 (show FKBP4 Antibodies)-DNA-binding activities. Moreover, the Akt (show AKT1 Antibodies)-mediated JNK1 (show MAPK8 Antibodies)/2 and ERK1/2 (show MAPK1/3 Antibodies) signaling pathways were involved in melatonin-regulated MMP-9 (show MMP9 Antibodies) transactivation and cell motility.

  8. we observed an association of FBW7 (show FBXW7 Antibodies) with p105 (show CDH13 Antibodies) and p65 (show GORASP1 Antibodies), as well as p100 (show CUX1 Antibodies), and knockdown of FBW7 (show FBXW7 Antibodies) eliminated 1,25D-dependent subunit turnover.

  9. results suggest that glucocorticoids induce a transcription complex consisting of RelB (show RELB Antibodies)/p52 (show FKBP4 Antibodies), CBP (show CREBBP Antibodies), and HDAC1 (show HDAC1 Antibodies) that triggers a dynamic acetylation-mediated epigenetic change to induce CRH (show CRH Antibodies) expression in full-term human placenta.

  10. DLX4 (show DLX4 Antibodies) induces CD44 (show CD44 Antibodies) by stimulating IL-1beta (show IL1B Antibodies)-mediated NF-kappaB (show NFKB1 Antibodies) activity, thereby promoting peritoneal metastasis of ovarian cancer

Zebrafish Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 (NFKB2) interaction partners

  1. Study indicates an essential role of NF-kappaB (show NFKB1 Antibodies) in gonadal differentiation

Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 (NFKB2) Antigen Profile

Antigen Summary

This gene encodes one of the subunits of the transcription factor complex nuclear factor-kappa-B (NFkB). The NFkB transcription factor complex is expressed in numerous cell types and functions as a central activator of genes involved in inflammation and immune function. The NFkB complex can consist of different subunits that form both homo- or heterodimers which bind specific kappa-B elements in target genes. This gene encodes the p100 subunit that is processed into the active p52 subunit. This protein can function as both a transcriptional activator and repressor, depending on its dimer partner. Alternate splicing results in both coding and non-coding variants.

Alternative names and synonyms associated with Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 2 (NFKB2)

  • nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 (Nfkb2) antibody
  • nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) (NFKB2) antibody
  • nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) (nfkb2) antibody
  • nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 (Nfkb2) antibody
  • nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 (nfkb2) antibody
  • H2TF1 antibody
  • lyt antibody
  • LYT-10 antibody
  • LYT10 antibody
  • NF-kappaB2 antibody
  • NF-kB2 antibody
  • p49 antibody
  • p49/p100 antibody
  • p50B antibody
  • p52 antibody
  • p100 antibody
  • p105 antibody
  • RGD1307189 antibody
  • wu:fa03b02 antibody
  • zgc:136693 antibody

Protein level used designations for NFKB2

DNA-binding factor KBF2 , NF kappaB2 , nuclear factor NF-kappa-B p100 subunit , nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 , lymphocyte translocation chromosome 10 protein , nuclear factor of kappa light chain gene enhancer in B-cells 2 , oncogene Lyt-10 , lyt-10 , nuclear factor NF-kappa-B p97 subunit , p100-NFkappaB2 , NF-kB2-I precursor protein , NF-kB2-II precursor protein , P100/P52 transcription factor

GENE ID SPECIES
18034 Mus musculus
4791 Homo sapiens
526392 Bos taurus
386574 Gallus gallus
486858 Canis lupus familiaris
397698 Xenopus laevis
309452 Rattus norvegicus
415100 Danio rerio
Did you look for something else?